Intranasal Esketamine administration in catatonia: a case report.

Intranasal Esketamine administration in catatonia: a case report.

Introduction Catatonia is a complex psychomotor syndrome that often goes unrecognized and, consequently, untreated. Prompt and correct identification of catatonia allows for highly effective treatment and prevention of possible complications. Benzodiazepines and electroconvulsive therapy (ECT) are...

Full description

Bibliographic Details
Main Authors:	J. Romay, C. Sevilla, P. Hernandez, I. Lastra, G. Isidro, L. Cayon, G. Cortez, O. Anabitarte, P. Ijalba, M. Gomez Revuelta
Format:	Article
Language:	English
Published:	Cambridge University Press 2023-03-01
Series:	European Psychiatry
Online Access:	https://www.cambridge.org/core/product/identifier/S092493382302028X/type/journal_article

Similar Items

The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01)

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
by: Maximilian Carter, et al.
Published: (2022-07-01)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)

Tolerability of intranasal esketamine, a case series of 15 patients
by: I. Álvarez Correa, et al.
Published: (2024-04-01)

The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
by: Maria Pepe, et al.
Published: (2023-10-01)

Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases
by: A. Mercado-Rodríguez, et al.
Published: (2023-03-01)

Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression
by: Katrin Skala, et al.
Published: (2023-06-01)

“Weight loss, Semaglutide and Manic Episode”: A case report
by: J. Romay Gonzalez, et al.
Published: (2024-04-01)

Intranasal esketamine efficacy as a treatment for treatment-resistant depression, case series
by: C. Delgado Marmisa, et al.
Published: (2024-04-01)

Median effective dose of esketamine for intranasal premedication in children with congenital heart disease
by: Jiajia Huang, et al.
Published: (2023-04-01)

A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children
by: Anna Nikula, et al.
Published: (2024-03-01)

How to have an acute gastroenteritis and an Anxiety Disorder at the same time: Cannabinoid hyperemesis syndrome (CHS) Case Series
by: P. A. Hernández Liebo, et al.
Published: (2024-04-01)

Real-world effectiveness and safety of esketamine intranasal spray combined with treatment-as-usual in psychiatric inpatients
by: E. Kavakbasi, et al.
Published: (2024-04-01)

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders
by: Miriam Olivola, et al.
Published: (2022-02-01)

Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01)

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
by: Johanna Louise Keeler, et al.
Published: (2023-05-01)

Combination of intranasal dexmedetomidine and intravenous esketamine for the sedation of pediatric patients undergoing cardiac magnetic resonance imaging
by: Min Diao, et al.
Published: (2024-08-01)

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
by: Ludivine Boudieu, et al.
Published: (2023-12-01)

Intranasal Esketamine + CBT: a 6 months follow-up of a resistant depression complicated case
by: V. Martiadis, et al.
Published: (2022-06-01)

Catatonia and dementia: a case report
by: E. Almeida, et al.
Published: (2022-06-01)

Malignant Catatonia
by: Ayca Ozkul, et al.
Published: (2010-12-01)

The Syndrome of Catatonia
by: James Allen Wilcox, et al.
Published: (2015-12-01)

The syndrome of catatonia
by: Milinović Milica, et al.
Published: (2020-01-01)

Catatonia Spectrum: Validation of a Questionnaire Investigating Catatonia Spectrum
by: Liliana Dell’Osso, et al.
Published: (2022-05-01)

Esketamine in resistant depression: a case report
by: L. Carrión Expósito, et al.
Published: (2024-04-01)

Clozapine withdrawal catatonia: A case report
by: Gopika Jagota, et al.
Published: (2023-07-01)

Catatonia in patients with dementia: a case report
by: Samira Younes, et al.
Published: (2019-06-01)

Comparison of intranasal administration of diazepam,
by: Abdolkarim Zamani Moghadam, et al.
Published: (2009-09-01)

Efficacy of intranasal dexmedetomidine-esketamine sedation for pediatric acceptance of facemask: single-center, double-blind, randomized, controlled trial
by: Kan Zhang, et al.
Published: (2025-02-01)

An Unusual Presentation of Catatonia-Like Behavior: Differentiating Malingering from Catatonia
by: Andy Y. Wang, et al.
Published: (2021-01-01)

Catatonia in patients with dementia
by: S. Khouadja, et al.
Published: (2021-04-01)

Maintenance electro convulsive therapy for recurrent catatonia – a case report
by: Nair V Indu, et al.
Published: (2018-11-01)

Clinical and psychopathological aspects of catatonia pathomorphosis
by: N. G. Neznanov, et al.
Published: (2020-04-01)

Catatonia: A Narrative Review for Hospitalists
by: Alyssa C. Smith, et al.
Published: (2023-12-01)

Worsening psychosis associated with administrations of buspirone and concerns for intranasal administration: A case report
by: Samuel Apeldoorn, et al.
Published: (2023-02-01)

Deep Vein Thrombosis with First Episode Catatonia: A Case Report
by: Sunilkumar, et al.
Published: (2015-04-01)

Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine
by: Mauro Pettorruso, et al.
Published: (2023-07-01)

Catatonia induced by abrupt discontinuation of clozapine - case report
by: C. Oliveira, et al.
Published: (2021-04-01)

Case report on antipsychotic induced catatonia in an incarcerated patient
by: Han Nguyen, et al.
Published: (2023-08-01)